Pneumotox
This program includes generic names for drugs and clinical or radiologic patterns of involvement.
Suitable for PDA's with:
PalmOs (Palm/PalmOne, Sony etc)
Suitable for PDA's with:
Microsoft Windows (HP iPaq, Fujitsu-Siemens, Dell etc)
Suitable for smartphones with:
Google Android
Patterns added for existing drugs:propofol (2B + 4B) , bucillamine (1B) , bevacizumab (3C), oxaliplatin (1G + 1L), 1n for mitomycin C (1N), abcavir (1D) , adalimumab (4A), contraceptives (6A)
Drugs added : darbepoetin, misoprostol, imiglucerase, lansoprazole
Pattern created : hemoptysis (3C)
In addition, some patterns are relabelled to be more accurate.
Changes V1.6 januari 2009:
Now you can also shorten the selection list of drugs in the Windows Mobile as well by entering the first character(s) of the name.
Changes V1.5 april 20th 2008:
Drugs added : cetuximab (1L), dasanitib (1B, 5A), everolimus (1B, 1D), botulinum toxin (9A)
Patterns added or modified for: ketamine (+8C), sirolimus (+4D), thalidomide (+6B), mercaptopurine (+1G +1L), azathiprine (+1D), azacitidine (+1A), doxorubicin +11A), heroin (+1D)
Changes V1.4 september 11th 2007:
Drugs added : amifostine, azacitidine, bortezomib, cisplatin, clomipramine, folinic acid, gemtuzumab, goserelin, omalizumab, oxaliplatin, telithromycine, temozolomide, verteporfin
Patterns added or modified for: BCG therapy (1m), clarythromycine (4a), clopidogrel (6f), cyclosporine (10c new)haloperidol (11g new), interferons (1m), imatinib (10a), leflunomide (1n new), methotrexate (1m), sirolimus (6f), tetracycline (4a)
Changes V1.3 april 7th 2007:
Drugs added: duloxetine and daptomycin
Patterns added to: topotecan (1L), celecoxib (11A), sirolimus (1E), thalidomide (1D) and infliximab (1B and 5D)
Changes V1.2 november 16th 2006:
Drugs added: Adalimumab, Anastrozole, Basiliximab, Epoprostenol, Imidapril, Phenazopyridine, Piperacilline, Risedronate, Temsirolimus
Patterns added to: 5-FU, Abacavir, Aminoglutethimide, Beclomethasone, Bepridil, Ciprofloxacin, Cladribine, Cyclosporin, Docetaxel, Etanercept, Gemcitabine, Imatinib, Infliximab, Propranolol, Rituximab, Trastuzumab